Ladies and gentlemen, good morning. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ebix Inc. Annual Results Investor Conference Call. Today's conference is being recorded. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press the star key followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one once again. Thank you. I will now turn the conference over to Darren Joseph, Corporate Vice President. You may begin. Thank you. Welcome, everyone, to Ebix, Inc.'s 2022 annual results earning conference call. Joining me to discuss the annual results is Ebix Chairman, President, and CEO, Robin Raina, President, Insurance Solutions, North America, Ash Sawhney, and Ebix EVP and CFO, Steven Hamil. Following our remarks, we'll open the call for your questions. Now, let me quickly cover the safe harbors. Some of the statements that we make today are forward-looking, including, among others, statements regarding Ebix's future investments, our long-term growth and innovation, the expected performance of our businesses, and our use of cash. These statements involve a number of risks and uncertainties that might cause actual results to differ materially from those projected in the forward-looking statement. Please note that these forward-looking statements reflect our opinions only as of the date of this presentation. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. Additional information concerning factors that could cause actual results to materially differ from those in the forward-looking statements made today are contained in our SEC filings, which list a more detailed description of the risk factors that may affect our results. Our press release announcing the 2022 full year and Q4 2022 results was issued today, this morning. The audio of this investor call is also being webcast live on the web at www.ebix.com/webcast. You can look at Ebix's financials beyond what has been provided in this release on our website, www.ebix.com. The audio and the text transcript of this call will be available also on the investor homepage of the Ebix website after 4:00 P.M. Eastern Time today. Let me discuss the quarter and the full year. This has been a record year in terms of revenue performance for the company, with the company reporting more than $1 billion in annual revenue for the first time. Fiscal year 2022 GAAP revenues increased 6% to $1.05 billion as compared to $994.9 million in fiscal year 2021. On a constant currency basis, fiscal year 2022 revenues grew to $1.1 billion, an increase of approximately $113 million or 11.3% over 2021 revenues. The increase is primarily due to growth in the EbixCash business, as well as our year-over-year growth in the company's core life and annuity exchange platforms, BPO and IT outsource services originating in India, foreign exchange business, travel business, e-learning and financial technology businesses, and growth in revenues in nine of the company's 11 major geographies. These increases were offset primarily by decline in the EbixCash prepaid card business. Besides declines in revenue within our U.S.-based consulting, employee health and wellness, and health exchange businesses, and the negative effect of substantial strengthening of the U.S. dollar on our revenues in the year 2022. Q4 2022 revenue decreased 4% to $255.2 million compared to $266.8 million in Q4 of 2021. The decrease is primarily due to the negative effect of the substantial strengthening of the U.S. dollar on our revenues in Q4 2022 as compared to the previous year. On a constant currency basis, Q4 2022 revenues increased 5% year-over-year and would have been $23.8 million higher in the quarter, but for foreign exchange rate changes during the quarter. On a constant currency basis, eight of the 11 major geographies worldwide had year-over-year revenue growth in Q4 2022. In Q4 2022, insurance exchange revenues worldwide decreased year-over-year by 2%, but grew around 1% on a constant currency basis. While risk compliance solutions revenue increased 14% year-over-year in the fourth quarter of 2022, and EbixCash revenue increased 7% year-over-year in the fourth quarter of 2022. Including the prepaid gift card revenues, EbixCash revenues increased year-over-year by 30%. Exchanges, including EbixCash and the insurance exchanges worldwide, continue to be Ebix's largest channel, accounting for 92% of our fiscal year 2022 revenues. For the 2022 fiscal year on a constant currency basis, nine of the 11 major geographies experienced year-over-year growth in revenues. For the full year 2022, EbixCash GAAP revenues grew 6%, RCS revenues grew 10%, while the insurance exchange revenues were essentially flat on a year-over-year basis. On a constant currency basis, insurance exchange revenues increased by 2% in 2022 as compared to 2021. On a constant currency basis, RCS revenues for fiscal year 2022 increased by 11% as compared to 2021, while EbixCash's revenues increased 14% year-over-year. On a constant currency basis, fiscal year 2022 worldwide revenues grew 11.3% over 2021 revenues. I will now turn the call over to Steve. Thanks, Darren. The U.S. dollar strengthened against most currencies during 2022 as pretty much everyone on this call knows. After experiencing the largest quarterly negative impact from foreign exchange movements in the third quarter of 2022, the fourth quarter of 2022 actually eclipsed Q3 2022. For the fourth quarter and fiscal year 2022, the negative impact from foreign exchange movement reduced our reported revenues by $23.8 million and $57.6 million respectively. Q4 and full year 2022 have been the largest quarterly and year-to-date negative impacts from foreign exchange movements in at least the past eight fiscal years for Ebix. Darren's already discussed the Q4 and fiscal year revenue figures, let me focus a little bit on the numerical drivers of those results. In 2022, the 5.5% revenue growth year-over-year was driven by growth in EbixCash's travel, foreign exchange, and outward remittance businesses, which on a combined basis grew 118% year-over-year. The BPO and IT services revenues in India grew 47% in 2022 versus 2021. Our EbixCash e-learning revenue growth was 160% in 2022. In Latin America, our year-over-year revenue growth was 42%. These strong growth results were offset in part by the prepaid gift card business in India, which declined 3.5% year-over-year, and I will note, generates little profit for Ebix. Australia had a revenue decline of 15% in 2022. About half of that was FX related based on changes in currency rates. U.S. revenues for the year decreased less than 1%, while our core life and annuity exchange revenues increased 5% year-over-year. Our consulting, health exchange, and EHAE revenue declines offset the solid growth in those core life and annuity exchanges. Our operating income in Q4 2022 was $29.8 million. That's an 8% decrease from Q4 2021 operating income of $32.4 million, and 2% lower than Q3 2022 operating income of $30.4 million. Our operating margin of 11.7% in Q4 compares to 11.8% in Q3 2022 and 12.2% in Q4 2021. The decrease year-over-year in our operating income relates primarily to increased personnel costs and rent expense, both primarily in India, as well as incremental sales and marketing expenses to continue to build the EbixCash brand in India. Employee-related expenses for salary and benefits increased $4.1 million in Q4 2022 versus Q4 2021. While rent expense increased $3.5 Million year-over-year in Q4 2022 as the company continues to reopen international airport and ports of entry locations as the negative impacts from COVID-19 subside. In India, our sales and marketing expenses increased by over $2.5 million in Q4 2022 as compared to Q4 2021. Excluding the impact of the prepaid gift card business, Q4 2022 operating margin was 26.4%, which compares to 26.3% in the sequential Q3 2022 quarter and 30.9% in Q4 2021. For fiscal year 2022 in total, our operating income was $120.3 million versus $119 million in 2021, an increase of 1.1%. On a constant currency basis, our operating income grew by approximately 5% year-over-year for the full year of 2022. During the year-to-date period of 2022, we had the following major cash uses: $33.2 million of cash interest paid, $24 million for income related taxes paid globally, a combined $21.5 million expended on capital expenditures and software development costs. $23.5 million used to reduce the principal outstanding on our corporate credit facility, $9.3 million for dividend payments. The company had liquidity on hand, which includes cash equivalent, short-term investments, and restricted cash of $136.3 million as of December 31, 2022, versus $125.2 million at 12/30/2021. I want to note that at December 31st, 2022, on that date, the company had interest and principal repayments under our credit facility due of $22.9 million, and $500,000 of which was principal repayment under the term loan. Because of an oversight at our agent bank, this payment was not taken from our account until the 1st business day of January 2023. Thus, our liquidity on hand at 12/31/2022 would have been $113.4 million had the payment been affected as of 12/31/2022, and that would compare to the $125.2 million at 12/31/2021. Our total debt on December 31st, 2022 was $647.3 million, a reduction of $13 million from total debt of $660.2 million as of 12/31/2021. As I just mentioned, the debt would have been $7.5 million lower at 12/31/2022 had that principal payment been processed timely. The company also paid down $5 million of principal on our debt in February of 2023 as part of the recent extension of our credit facility to mature in May 2023, and we will repay an additional $5 million under that facility on March 31st, 2023. Our current corporate credit facility contains two financial covenants, a consolidated net leverage covenant and a fixed charge coverage covenant. Our consolidated net leverage ratio was approximately 3.6 x at 12/31/2022 versus 4.2 x at 12/31/2021. During 2022, we delevered approximately 0.6 turns. Our consolidated net leverage covenant at 12/31/2022 was 4.5 x. We were comfortably under that covenant level. Our fixed charge coverage ratio was approximately 1.5 x at 12/31/2022 versus our covenant level of 1.25 x. We were in compliance with our credit facility financial covenants at 12/31/2022. Robin will provide a further update on the efforts that are ongoing to address the impending maturity of the credit facility in May 2023 during his remarks. We are appreciative of the syndicate of banks that are working with us as we continue to pursue the refinancing of our credit facility into a capital structure that is both longer in tenor and with more globally oriented investors. Ebix continues to generate significant adjusted EBITDA despite global economic stress, including inflation in a rising rate environment and lingering impacts from COVID-19 pandemic. In 2022, the company generated $142.8 million of EBITDA plus non-cash stock comp expense. That's an increase of $3.2 million or 2% over 2021 levels. Reaching pre-COVID-19 operating levels in the negatively impacted businesses is a goal we are continuing to move towards. While we saw a rebound in activity in most of these businesses beginning late in 2021, Q4 2022 revenues remain depressed from pre-COVID-19 levels. Q4 2022 revenues from travel, foreign exchange, remittance, financial technologies, and e-learning businesses at EbixCash were 27% lower than Q4 2019 revenues, which is the last quarter prior to the beginning of the negative impact from COVID-19 on our company. However, just one year ago, these business lines were approximately 53% lower than Q4 2019 revenues. In 2022, we made significant progress in returning to pre-COVID-19 operating levels, and our goal is to return quarterly revenues for these businesses to those pre-COVID-19 levels in late 2023 or early 2024. While we have some important hurdles to clear in the coming months, most notably changing our capital structure to address the corporate credit facility maturity, we continue to believe that the market positions we have obtained through years of service to our customers will, over the long term, lead to a strong and successful company that will provide value to all of our stakeholders. Our employees work hard every day to deliver for our customers, and I wanna thank the over 10,000 folks that really define Ebix to the marketplaces that we serve. Finally, Ebix's Form 10-K will be filed later today, and I would like to now turn the call over to the president of our North American insurance businesses, Ash Sawhney, for his remarks on our fourth quarter and fiscal year 2022 operations. Thank you, Darren and Steve. I will now talk about the Q4 2022 and full year 2022 analysis of the North American business. The Q4 2022 revenue was up 6% compared to Q3 of 2022 for North America. This was enabled by a cyclical increase in our medical certification business and the strong performance of our life and annuity exchanges. On a full year basis, the 2022 revenue for North America was relatively flat compared to 2021. Our worldwide insurance exchange business grew by around 2% in 2022 as compared to 2021. In 2022, our core insurance exchange, which constitute roughly 70% of our revenue, continued to grow to show steady growth. The life, annuity, property and casualty, and health exchanges were up 3.5% in aggregate. The Q4 revenue in aggregate was down 3% compared to Q4 of 2021, largely on account of softening in the medical certification division. This group was up 50% sequentially in Q4, but down 11% over the same quarter in 2021. I will now provide a more granular analysis of our various business units. The life and annuity exchanges, including life and annuity order entry, illustration, CRM, and underwriting exchanges were up 4% in Q4 compared to Q3, up 7% in Q4 compared to the same quarter in 2021, and up 5% on a full year basis comparing 2022 to 2021. The annuity exchange, which is the largest of all our exchanges, continued its strong run. Revenues were up 8% in Q4 2022 sequentially, up 23% compared to Q4 2021, and on a full year basis, the revenue was up 20%. Q4 2022 was the highest revenue quarter on record. 2022 was the highest year on record, and November 2022 was the highest month on record. Total number of carriers now exceeds 57. Total transactions processed exceeded 580,000, and the total premiums processed through the platform now exceeds $98 billion in 2022. These were all record numbers. Approximately half of the annuity growth in 2022 came from increased business from our existing customers, and the other half came from new clients added to the platform over the past 18 months. We added CNO and Ohio National to our client list in Q4. Our life exchanges, comprised of life order entry, illustration, and CRM, were collectively up 2% in Q4 compared to Q3, and also up 2% for the year. The platforms collectively processed over $50 billion in premiums. The number of carriers on our various life platforms now exceeds 100, and the number of distributors exceeds 100,000. We ran over 30 million illustrations on the life platform in 2022 and processed over 1.3 million applications. These were all record numbers. The underwriting division was flat in Q3 compared to Q4 compared to Q3. On a full year basis, the business was down 5%. We are seeing signs of the division starting to recover from the resource constraints discussed previously. We have added several new capabilities to the platform, which will provide incremental revenue streams in the future. These include a reinsurance module, processing for annuities, and processing capabilities for Bermuda and Singapore businesses. Last year, we embarked on an effort to restructure and reposition the Ebix CRM division. More specifically, we increased our focus on the retail market segment, particularly in the mid-tier BGA segment. We repositioned the platform as a one-stop gateway for advisors to conduct all their business, such as managing customer data and communication, submitting new business, getting case status updates, managing commissions, and conducting other day-to-day functions. The platform is now tightly integrated with all Ebix tools, including quoting, illustration, and order entry. In addition, the platform provides integration with over 74 third-party systems, enabling a vast ecosystem accessible through a single gateway. We are starting to see a turnaround in this business. Retail sales were up 21% in 2022 compared to 2021. Revenue was up 3% and attrition rates were reduced by 50% during the same period. Our health benefit administration business was down 8% sequentially in Q4 of 2022, largely because Q3 left a high watermark in terms of quarterly revenue. The business was flat in Q4 compared to the same quarter the year before, and on a full year basis was up 3.5%, delivering the highest yearly revenue this group has ever recorded. This business continues to generate steady revenue with over 77 large payer customers, servicing over 43,000 employer groups and covering over nine million lives. We are on track to onboard Aon in Q2 of this year, which will provide an uptick in our subscription revenue. Our medical certification business, Oakstone, was up 50% sequentially in Q4 compared to Q3 of 2022. This cyclical spike was expected as the division derives approximately a third of its business in Q4. Compared to Q4 21, the revenue was down 11%. This decline was partly due to the changing dynamics in the gift card incentives that are bundled with the subscription offers, and partly due to the life cycle decline of the audio content product, which typically gets 60% of the revenue in the first half of a four-year life cycle. That product happens to be in the second half of its life cycle. We are working on several initiatives to increase revenue, including targeting products towards younger physicians and also adding new mobile-enabled capabilities. Oakstone remains a strong brand in the continuing medical education space with over 50 years of history. We service two out of every 10 physicians in 30-plus medical and dental specialties. Our content is created in partnership with leading medical institutions such as Harvard Medical, Cleveland Clinic, Brigham and Women's, Dana-Farber, Johns Hopkins, and 20 other such institutions. The consulting business was up 3% in Q4 compared to Q3, and down 2% for the full year. As was outlined in Q3 of 2022, we are now packaging our consulting services for our new and existing exchange customers. Packaged under a program called Accelerated go-to-market, AGM, we now offer strategy, product design, onboarding support, testing, and training services to our exchange customers. Most new clients will be availing of this service, including CNO and Ohio National, who were signed on in Q4, and will be receiving several of these services in the coming quarters. We also signed new contracts with Equitable, Symetra, and RW Baird in Q4. Our P&C business, the smallest of our vertical business units, was down roughly 6% in 2022 compared to 2021. In Q4, we rolled out a new release of the RiskEnvision product, one of the main product lines in this group. We are seeing a healthy pipeline and expect 2023 to show growth over 2022. The risk compliance business was down 8% in Q4 compared to Q3, which was a strong quarter for us. On a full year basis, the business was up 3%. This business continues to be a steady performer for us with a 28-year history, serving over 600 customers, including 70 of the largest Fortune 500 companies. Looking forward, we feel optimistic about the path we are on. Several factors contribute to our optimism, which are outlined as follows. The current macroeconomic environment is favorable to several of our core units, such as annuities. The high interest rates are providing a strong tailwind for the industry. This is increasing the number of annuity transactions and also bringing new entrants to the market. Both these are favorable trends for our business. We are seeing an uptick in transactions continuing into the early months of 2023. More on this when we report our Q1 2023 earnings. The jobs market is continuing to cool off in our industry. Over the past few months, we have seen a marked progress in filling our backlog and have also seen a drop off in attrition rates. We also reorganized our delivery organizations and exchange division in 2022. We were previously organized by product line, which had limitations and redundancies. We have now aligned ourselves with a centralized customer-focused operating organization, including client services, product strategy and development, and production support. This structure will be important as we see ourselves selling and servicing comprehensive digital solutions that encompass several of our products. We are excited about our new sales organization. We fully rebuilt our sales organization in 2022, with the majority of the sales organization having been hired within the last 12 months. These newly hired experts serve as client partners and are viewed by our clients as solutionists for helping them find the right fit for their technology needs. This setup allows us to better serve our customers and optimizes the penetration of our products within our existing client base. We are already seeing positive results. The number of customers using three or more of our products and services has improved by 20% in the past year. The pipeline going into 2023 is healthy. Ebix has always been at the forefront of product innovation. In line with this legacy, Ebix is launching the Superhighway, its most advanced exchange to support life and annuities processing. This new Superhighway is designed to significantly unify and enhance the advisor experience in selling life and annuity products. It is a well-known fact that the selling process across the industry is fairly disjointed, wherein the advisor has to navigate through multiple subsystems across the life cycle of selling a policy. Super Highway will solve that problem. From customer needs analysis, product research, quoting, illustration, order submission, policy issuance, and post-issue policy maintenance, the advisor will be able to navigate through a unified and streamlined user experience, an experience that will be aided by data-driven artificial intelligence, guided user activity, machine learning, and natural language processing. The Super Highway was unveiled at the recent Ebix Exposition in Orlando. We believe the expansion of the annuity sales will also increase the need for post-issue policy servicing. This includes both financial and non-financial transactions such as policy changes, withdrawals, fund transfers, dollar-cost averaging, and asset rebalancing. Ebix has already developed a solution called Annuity Maintenance Platform, called AMP. We believe the adoption of AMP will increase considerably as the market for annuities in general continues to expand. Overall, we are excited about the outlook for our North American business. As some companies brace for an uncertain economic environment, our business in North America will continue to be resilient. This stems from wide array of products that collectively provide a natural hedge in any economic climate. Our strength is also founded on a very diverse set of customers, which includes hundreds of insurance companies and banks, tens of thousands of advisors, dozens of top medical institutions, and several of the top Fortune 500 companies. Our pricing model, which is largely recurring in nature, adds to the solidity of our business model. We are mindful of the important part we play in running some of the largest exchanges in the industry. This is a responsibility we take very seriously. I'm grateful to all the Ebix employees who work hard to make it all happen. I will now pass it along to Robin for his comments. Good morning. This has been a record year for Ebix in terms of revenue, with the company clocking approximately $1.05 billion in GAAP revenues. For me, a few things stand out as regards to annual performance. Constant currency revenues of $1.1 billion with 11.3% year-over-year growth. On a constant currency basis, all three channels of the company showed year-over-year growth. Constant currency insurance exchange revenues increased by 2% in 2022 versus 2021. On a constant currency basis, RCS revenues increased by 11% as compared to 2021. On a constant currency basis, EbixCash revenues increased 14% year-over-year. On a constant currency basis, nine of the 11 major geographies experienced year-over-year growth in revenues. In 2022, the company generated $142.8 million of EBITDA plus non-cash stock compensation expense, an increase of $3.2 million or 2% over 2021 levels. I compared the 2022 numbers to 2020 fiscal year numbers to get a perspective on the overall business growth. Between 2020 and 2022, worldwide GAAP revenues have grown by 68%. Between 2020 and 2022, EbixCash GAAP revenues have grown by 112%. While comparing 2022 fiscal year numbers with 2021 fiscal year numbers, the performance of a few international operations in addition to U.S. and India was especially noteworthy. Latin America year-over-year grew by 42%. Singapore year-over-year grew by 10%. Indonesia year-over-year grew by 261%. Philippines year-over-year grew by 91%. Middle East year-over-year grew by 30%. As regards to quarterly Q4 2022 year-over-year performance, a few things to note. On a constant currency basis, Q4 2022 revenues increased 5% year-over-year and would have been $23.8 million higher in the quarter, but for foreign exchange rate changes during the quarter. On a constant currency basis, eight of the 11 major geographies worldwide had year-over-year revenue growth in Q4 2022. In Q4 2022, insurance exchanges worldwide increased 1% on a constant currency basis. Risk compliance solutions constant currency revenue increased 14% year-over-year in the fourth quarter of 2022. EbixCash constant currency revenue increased 7% year-over-year in the fourth quarter of 2022. Excluding the prepaid gift card revenues, EbixCash revenues increased year-over-year by 30%. I'm also pleased with the operating cash flow performance in the quarter, with the company reporting $32.5 million of operating cash flow in the fourth quarter of 2022. We started the year with cash equivalents, short-term investments, and restricted cash of $125.2 million as of 31st December 2021. As of 31st December 2022, we still had net cash of $113.4 million after accounting for the $22.9 million late withdrawal by the bank. This was after the company cumulatively spent $111.5 million in 2022 just on a few key areas. $33.2 million of cash interest paid. $23.5 million used to reduce the principal outstanding on a corporate credit facility. $24 million for income-related taxes paid globally. A combined $21.5 million expended on capital expenditures and software development costs. An additional $9.3 million for dividend payments. We had $98.7 million of cash equivalents, short-term investments, and restricted cash as of 30th September 2022. As of 31st December 2022, we still had net cash of $113.4 million. All of that speaks to the cash generation abilities of the company. At the present minute, I have limited ability to speak on the debt refinancing front as we are governed by tight confidentiality agreements with any and all entities involved. Management continues to work with the company's board of directors and outside financial and legal advisors to address the refinancing of its credit facility, which the company, in cooperation with syndicate of banks, extended to May 23, 2023, in order to give the company time to continue to pursue alternatives that will refinance the credit facility. The company has multiple options that it is exploring to ensure that the credit facility is largely or wholly refinanced as quickly as possible. Rest assured that we are fully aware that while our operating income continues to be strong, our net income is getting negatively affected by the high cost of bank interest and associated legal and advisory fees associated with the refinancing and extension exercise. We also believe that once the EbixCash IPO is carried out successfully, it is expected to reduce our interest costs substantially. In the meanwhile, we are working with our financial advisors, Jefferies, on a number of possible options. Our goal remains to seek a structure that is in the best interest of all of our stakeholders. Our business is thriving and healthy worldwide. Our operating metrics are strong and our senior management convinced about the opportunity ahead of us. In the long term, we are focused on resolving the non-operating metrics like interest costs and some of the non-recurring costs that we are presently incurring on advisors, et cetera, associated with the refinancing. We have a plan in place to grow our operating income further and try and reduce extraneous costs. Our first priority is to handle the debt refinancing in the short term and then have a cost structure that ultimately is set for income maximization. We would like to get to that ultimate plan in 2023 itself. Are working towards it. Success isn't always about greatness, it's about consistency. At Ebix, we are firm believers in this quote from Lewis Carroll. We will continue to strive to deliver consistent revenue growth and results that we can be proud of. After 23 years of consistency in terms of growth and other operating metrics, Ebix has proven that it is completely committed to achieving greatness on the foundations of consistency. We are thus committed to creating a capital structure that maximizes value for our stockholders. In closing, as always, I want to thank our customers, our partners, and our employees for their continued trust in us and for contributing to an outstanding fiscal 2022. With that, I will now pass the call over to the operator and open it up for questions. Thank you. Thank you. At this time, I would like to remind everyone, in order to ask a question, press star and then the number one on your telephone keypad. If you press star one a second time, it will remove you from the queue. We will pause for just a moment to compile the Q&A roster. We will take our first question from Jeff Van Rhee with Craig-Hallum. Your line is open. Great, thanks for taking the question. Robin, with respect to the credit agreement, there's a few lines in there talking about Ebix is to provide a strategic plan on or before March 15. Was that done? With respect to communication with shareholders, what can shareholders expect to hear as this process evolves? Jeff, first of all, yes, meaning we absolutely will be in time with respect to the 15th deadline. Rest assured about it. I didn't get your second question. Can you please repeat that? The first was just whether or not you provided that strategic plan on or before today, and then the other one was, in terms of shareholder communication, what is it that they can expect? I mean, presumably in that communication to the board creditors, et cetera, you evaluated options, from all the way from selling parts or all the business to various credit options to, I would imagine, a very wide range. Seemingly you presented that. What does it look like for the next, you know, three, six, 12 months for shareholders in terms of how... What they're going to hear and what they're going to know about what's going on? Well, our goal is to be as transparent as possible with our shareholders within the rules. Having said that, we have a next deadline, as you know, of May 23rd, that we are, our extension is still May 23rd. Our shareholders are definitely gonna hear from us on the path we undertake at that point of time. I think between now and then, it's extremely difficult for me to give, to lay out all the possible options, all the different things that we're working on, simply because we, like I said in my talk, we are governed by confidentiality provisions, and it wouldn't be prudent or right for me to be able to speak about it. Mm-hmm. On the. Hey, Jeff. Yep. Jeff, this is Steven Hamil. Just to be totally clear, that strategic plan was finalized a few days ago and will be delivered to our bank group today. Whether it has been delivered as of 11:41 A.M., I'm not 100% sure. That will be delivered through our advisors to the bank group. Yes, it will be delivered today. Okay, great. I appreciate that. With respect to the IPO, I mean, understanding your hands are tied in many ways to comment on this. It's about a year since the filing. SEBI appears to be a mess. they've struggled to move things forward at anywhere near the pace they used to kind of across the board. Clearly Ebix is an outlier. I realize you're not going to give me exact timing, but, you know, any observations about the overall market without talking to your specific instance that would be relevant for investors watching this process and wondering why SEBI is not moving? I couldn't really comment on why SEBI isn't moving. Look, it's very hard for us to comment. At the same time, we would hope and believe that we should get, at some point, we're gonna get that approval sooner rather than later. Having said that, you know, some of it, as you know, Indian market, stock markets have gone through a lot of turmoil in the last a month and a half especially. It could be that that has something to do with the delay in terms of there's a lot of stuff happening in India, and a lot of IPOs have gotten delayed from an approval perspective from SEBI, right? Because, having said that, we'd like to believe that we are going to get our approval sooner rather than later. Our bankers, as I said earlier, are fully geared up. All five bankers are ready to pounce on it, ready to launch their marketing attempts, and so on. We, it could happen anytime, Jeff, and it's impossible for me to tell you something until we hear back, until we hear something from SEBI. Okay. Two other questions then, market share-wise, if I break it up between EbixCash and then the North American business, you know, obviously, COVID has depressed a lot of the EbixCash businesses, but would you say you've gained, held, or lost share since pre-COVID? I'd ask the same question separately about the North American business, gained, lost, or held share? Well, with respect to EbixCash, I can absolutely tell you we have absolutely gained in market share in almost every market segment that we operate in. The COVID became, you know, with all its negativity, it ultimately became an opportunity for us because some of the smaller players just died by the wayside. Meaning, if you just look at, I could go one by one and walk you through Forex, remittance, meaning, travel, you're gonna see that we've actually done quite well in terms of our percentage share in the market. You know, whether you count the number of airports we had, we have before the, you know, as COVID started going away, if you look at the number of airports we had for Forex and what we have now, you know, the number keeps increasing virtually by the, by the day. Meaning, almost a few days back, we actually had one of the largest airport approvals. One of the airports that we didn't have, just came to us in the last three, four days. Having said that, I mean, I could go on in Forex in terms of our corporate market share or our airport market share or our port market share and so on. Similar provisions go on, whether we talk about educational remittances, where our market share has substantially increased. It's a function of what is the overall market size. If you look at the overall market size, and that gets depressed by COVID. Now, the question is, are we gaining in market share with respect to what is the present market size? The answer is an absolute resounding yes. You know, I could go into bus exchange area where we have kept announcing deals, and hopefully we'll announce more deals in the coming days, and so on. There is, there's a lot of positive momentum that and it gets reflected in the growth in revenues that we have shown with respect to EbixCash. Ash, you wanna comment on the U.S. side of the business? Certainly. Jeff, you know, looking at North America, you would have to look at the different subsegments of the market. As an example, our life and annuity exchanges, I would say over the last, you know, 12 months would have certainly increased market share. The way we look at that is based on the number of transactions that are going through our platforms. We have added, you know, more carriers and more distributors on the platform in the last, you know, 12-18 months than we have done probably in the last, you know, five years before that. On the life side, specifically, you know, we've added, we've increased the number of carriers on our platform quite significantly. Ultimately, that's a key driver in terms of, you know, increasing the market share. In some of the other divisions, like our Ebix Health division, I would say it's probably relatively flat. We are adding a big international broker to the platform, which is, you know, a fairly significant deal for us. We believe that that itself will also increase our, you know, subscription revenue. In certain other areas, such as, you know, wellness, other areas such as our P&C business, it's more or less, you know, flat to a slight decline. These businesses now represent a much smaller part of our overall business, Jeff. Our focus really is the core, which I defined as, you know, our life annuities, the Ebix Health business. These are all businesses that are, you know, fairly solid. Okay, that's helpful. Jeff, sorry. Ash probably would add the RCS certificate business as a core business-. Yes. in terms of Yeah. Yes, exactly. Yes. The RCS business, you know, it stays steady. We do business with, like I said, over 70 of the largest, you know, Fortune 500 companies. We have continued to, you know, keep a pretty significant place for ourselves in the industry. We are a very well-recognized brand. Same with Oakstone. You know, we are probably one of the larger players in the CME business. Market share is probably up or down a little bit, but the key point is it's a very solid business for us, and we expect to continue to, you know, grow some of these business units. Robin, and/or Ash, you know, you might wanna add a little color around the EHAE joint venture and how that's been a bit of a drag on revenues for the last couple of years. I mean, basically, when you look at the overall revenue, EHAE revenue has mainly fallen, as I've talked about in the previous call. It's our TPA business. In a TPA business, when you look at the cumulative revenue, you know, the fall in that EHAE revenue gets reflected, and it offsets some of the increases that we show in some of the other businesses that Ash kept talking about. The TPA business, one of our main reasons was our joint venture partner basically decided to get out of health business completely, and they were one of the largest clients for us, and that just went away from one day to another in a way. That has obviously caused a bit of pain in terms of revenue. It is one business where, you know, there are not many businesses where Ebix would be saying that we lose any money. This is a business where we actually have a bit of a negative, you know, profitability, a bit of losses out there, which we are trying to. You know, as we figure that one out, we're basically actively working on trying to figure that one out. We're trying to figure out, can we get our JV partner completely out of things candidly. If we can do that, it actually there are ways and means to make that business a lot better. We're a bit hindered by the fact that we have a JV partner who's actually out of business and is not able to contribute. In turn, we have some obligations attached to that client, which actually costs us a bit of money. There's a bit of room there for us to gain in terms of profitability, is how I see it. It's a fairly small business right now, fairly minuscule for us right now. Okay. Last for me, a couple model-specific questions. As I look at the GAAP net income, it's about a $6 million miss versus my estimate, and about $5 million of that comes below the operating line. I think I can model out the interest expense going forward. That leaves the other big variance this quarter. The two were interest expense and primarily taxes. Two specific questions. How should we think about taxes in 2023 and specifically in Q1, the year as well? G&A, you touched on it. I mean obviously it's running fat here, up considerably over really any trailing periods. You called out rent and a few things that seem like they will persist. I'm wondering if this $36 million, non-GAAP, run rate, or actual print, $36 million of G&A in Q4, if that's the right level to assume going forward. really two questions there, taxes and G&A. Yeah. I For Robin. Yes. You wanna talk about G&A first? Can I provide a little- Yes, please do. Please do. I'll add to it. Yeah. Can I provide a little color? Go ahead. Jeff, at the beginning of 2021, our borrowing rate was 4%. Through rising interest rate environments, increased spreads, as we had to do an amendment for COVID, you know, our borrowing rate has increased pretty materially. If you look at the end of 2021, our borrowing rate was 5.5%. At the end of 2022, our borrowing rate was 9.6%. In two years, we've gone from 4%- 9.6%, largely as a result of increase in the LIBOR rate. Today, our borrowing rate is just under 12% as rates had continued to persist, and we had a little bit of an increase in our borrowing spread. You know, additionally, in 2022, we had a couple of different payments to the bank group that were fees associated with, you know, having not refinanced the deal by certain measurement dates. In 2022, we spent probably $2.65 million out the door to these banks, those were capitalized as deferred financing costs. If you think about, you know, probably $2.1 million of that was amortized into expense during 2022. In the fourth quarter, that number was probably about $900+ thousand of interest expense related to those one-time fees. We've been hit by a rising rate environment, an increase in our spreads, and increased fees and out-of-pockets related to the bank group. From a tax standpoint- Jeff. Jeff, from a tax standpoint. Go ahead. Sorry. From a tax standpoint, Jeff, you know, our starting point for, you know, pre-tax book income wasn't materially different, 2021 - 2022. There's a couple of big things that have caused the effective tax rate to go from 9% - 13% during 2022. Really, the first one is just the amount of foreign related income in higher tax jurisdictions that has been generated and included related to GILTI calculation. Really the second one is, you know, temporary differences around. You know, in the Trump Tax Act, there's a Section 163(j) provision which limits your business interest expense deduction. I'm not gonna quote absolute numbers, but it's about 30% of your adjusted taxable income. Given the increased amount of interest expense we've had, that differential year-over-year from 2021 - 2022 increased our taxable income by close to $8 million, just that one item. Those two items were the two biggest ones that contributed to the effective tax rate increasing from kinda 9%-13%. Would that suggest then we would normalize at that rate? I mean, it doesn't seem like the Tax Act is going to change. Is that the how to think about the rate going forward? Steve, you want me to answer that? Yeah, go ahead, Robin. Yes. Let me answer both. I'll add to what Steve just talked about interest, and I'll talk about the tax sale. I expect the tax rate to be in single digits for this year. There are a number of reasons for it, but we can go through that. Basically, I would expect that to be somewhere in the 6%-8% kind of a bracket in terms of the tax rates. The second question of yours was when you talked about the interest rates, how do you know, model all of this forward-looking? I think the way to look at it is there's short-term, and then there's long-term. In the short-term, obviously, we have costs in terms of Steve already talked you through the interest costs that we have. Clearly, that is something we have to live with until we have paid our banks back. Now, even if we refinance, the question becomes, it all depends on the capital structure that we have chosen. There are capital structures. To give you a simple example, let's say we had a successful IPO or we launched our IPO. Now, our net interest costs are going to be relatively low simply because we would have raised money through equity, which doesn't have any costs associated with it. Whether you keep that money in a bank earning interest or whether you use that to pay back, reduce your debt in any way, meaning it ultimately results in a net reduction, a pretty substantial net reduction in terms of interest costs. On a long-term basis or, you know, it all comes down to how soon can we get our IPO done. If we can get our IPO done, meaning a lot of these costs will reduce dramatically. Having said that, in the meanwhile, we have to live with what we have, and we have to make sure we strive for every option out there to obviously pay our banks and refinance in the meanwhile. That's exactly what we are doing. For that, Steve already talked you through the cost of interest that are presently being incurred. Yep, fair enough. Got it. Thanks for taking the questions. Thank you, sir. We'll take our next question from Chris Sakai with Singular Research. Your line is open. Yes, hi. I just had a question on the annuity exchange. What were the main drivers as far as the increase in carriers and distributors in 2022? What can we expect in 2023? Ash, please go ahead. Sure. Yeah, I can take that. You know, the economic climate right now, especially with the high interest rates, that is a big factor, obviously, because, you know, annuities are paying, you know, higher interest rates. There's more, you know, annuity sales happening in the industry. More carriers that were not previously in the annuity space are jumping in. Another big factor for us over the last, you know, I would say 12- 18 months was the onboarding of JP Morgan, who is one of the largest, you know, annuity players in the industry. When you bring somebody like that onto the platform, you know, all their carrier partners have to start, you know, participating on the exchange. You know, we're seeing higher volumes across the board, you know, because of the economic climate. We're also seeing new entrants come in. Like I outlined, about half of the growth actually came from more volume from existing customers and the other half from these new entrants. In terms of 2023, I would say, you know, we expect as long as the interest rates stay where they are, you know, we're gonna continue to see, you know, fairly healthy growth. In fact, for the first two months of this year, we have continued to see the same pattern that we saw in Q3 and Q4. The volumes are way up there. Chris, I want to add to what Ash said. I think we're also at a pivoting point. What has happened is that our dominance, if I'm allowed to use the word dominance, has continued to grow in this field. We've continued to grow our market share in this area. What that has done is when you have that, when you have that kind of dominance or market share, it leads to a networking effect, and it leads to some of the larger distributors who may not. Let's say there is a distributor, ABC, who might be on your competitor's platform. There is every reason for now for that large distributor to come to you for many reasons. One, you have all the network sitting out there, which is the network they want to address. On the second side, we have the volume. Since we have the volumes, we can afford to do all this cutting-edge development, design the latest and the greatest of products, which a smaller player who has a smaller market share cannot afford to do simply because they don't have that appetite because they don't have that revenue stream. It's impossible for them to put those kind of costs in. Net result of that is that you get to a point in exchanges where the people will approach you rather than you approaching them. We are seeing some of that phenomenon happening. I would be very disappointed if in the next one year, we don't candidly see some of the major clients that our competition has to come to us. We would like to see that, and we believe there is every reason to see that. I have a reason to say it. Thank you. Okay. Thanks for that answer. And then prepaid card side of things, what was the reasoning for the decline there? Look, you have to see the market size. What happened was, during COVID, there was a pretty big growth in the prepaid card business, mainly because people didn't wanna touch things, digitization dramatically increased. This was a normal process that has set in terms of the size of the market. First of all, there was an absolute rush for prepaid cards during COVID. Once COVID became a thing of the past, that rush reduced a little bit. Secondly, candidly, it has to do with the commissions associated with that business. When we do that business, part of our commissions are shared with sub-agents that we have. Now it all depends on our business model. If we are prepared to share a larger part of our commission, this business revenue can be a lot higher than what we are reporting. It's just that we're not prepared to do that. We like to run profitable businesses. A lot of our competition in this business segment, you know, is willing to pass on most of their commission to their sub-agents and agents simply because it gives them top-line growth. We chose not to do that, and we decided that we're gonna, you know, we're gonna live with the business model that we have of profitability. Within that business model, we will continue to see how well we can do. That's the reason for what you see out there in the prepaid card business. Let me just al. Okay. Let me just also add some perspective from a CFO's standpoint. You know, honestly, this business doesn't generate material cash flow or income for us, okay? I don't really care whether we do $600 billion of sales in the gift card business, $400 million, $800 million. My biggest concern as the CFO, and Robin to the same degree, is how much money are we making, right? How much EBITDA are we generating? How much net income are we generating? I never want the analyst community or investors to get caught up in this prepaid card business because the way it, the competitive dynamics of it in India, it's just not a material generator of profit. Chris, what we are now also trying to do. Now that we have the reach and the expanse as one of the largest non-banking players in the prepaid card business, we're using that. I'll give you an example of a recent example of where we are deploying these prepaid card products, one area, and in a very profitable manner. One is we signed an agreement with the West Bengal government wherein in West Bengal, every roadways bus, we are providing the bus exchange system to basically wherein every ticket that gets sold is happening using smart technology, using our technology. What we also did, we worked with the government in there to introduce all these prepaid cards for consumers. With the EbixCash prepaid card, basically the consumer, the West Bengal Transport Department, for example, decided to offer a discount, a slight discount on their prices. Net result is now you have a reason for people who are traveling in those buses to start using that prepaid card simply because it gets them a discount, plus it gives them the digital ability to use it on the bus and so on. We were able to position ourselves in... West Bengal is just one opportunity. We are presently deploying it across. We are trying to basically convince all the 16 states where we do business to deploy this. Another good example is take the largest state of India, which is Uttar Pradesh. Uttar Pradesh is the largest state in population and metrics that the neighboring countries to India, whether it's Pakistan or anybody out there. If you look at what we are trying to do out there, UP government distributes a lot of, you know, they dole out a lot of money to widows, to the underprivileged through the government program every month actually. We are trying to do that through working with another bank. We're trying to deploy all these cards that would be issued with the consumer's picture on top of that card so that when any money is doled out, it is done on the basis of that comparing that picture, comparing their biometrics, their thumb imprints, and from there, having a EbixCash card whereby the government can now track the money that they doled out, how was it really used? Is it coming back into the economy or not? Those are the kind of examples of clients that we are now adding with respect to the prepaid card business. It's a business that ultimately, look, we have a pretty substantial market share, and we kind of feel now we are trying to make this into a good income opportunity also. But we wanna do it at our terms. You know, we're focused on income, so we're not gonna just, you know, go into the markets and increase market share just by reducing our commissions or passing on more commissions to agents. We wanna actually maximize our income while selling more cards. Does it make sense? What I talked to you about, Chris? Yeah. Yes, it does. Thank you. Along with the bus systems, how is that coming as far as the ITMS, as it is, as you bring it out into new state bus systems? We are continuing to deploy all the ITMS systems and all the deals that we've been announcing, whether we announce Andhra, whether we announce West Bengal. Recently, we announced a large, one of the largest deals we have done, MSRTC, Maharashtra State Roadways Transport Corporation, wherein we have two phases. We first will deploy ITMS across, I think 19,000 buses, then it is across approximately 38,000 buses overall. It's a very large state with 38,000 buses plying, where everybody would be able to use these smart card, and we get paid on a per ticket basis. It's a very simple business model. Virtually every ticket, we don't really care whether it's... You know, of course, they will be able to use our prepaid cards, but whether they're using any UPI, whether they're using, you know, whether they're using Paytm or whether they're using virtually, Google Pay or anybody, we're gonna make money on every ticket. That's our business model, that's how we are deploying. We are in the midst of a few very large interesting deals right now with some of the states that we don't have, hopefully I have something positive to report in coming weeks and months on that front. Okay, great. Thanks for the answers. Thank you, sir. Ladies and gentlemen, that is all the time we have for questions today. This will conclude today's conference call. We thank you for your participation. You may now